KJIM :: Korean Journal of Internal Medicine

The trading of space for time under weakly activated catalysis: expeditious synthesis of β-NH2alcoholsviaa direct ammonolysis of epoxides with ammonia

Guolan Ma, Chang Xu, Shaoxiong Yang, Yanren Zhu, Silei Ye, Rui Qin, Chongchong Zeng, Wenqiang Du, Hongbin Zhang, Jingbo Chen

Safety profile of COVID-19 drugs in a real clinical setting

Mei Nee Chiu, Maitry Bhardwaj, Sangeeta Pilkhwal Sah

European Journal of Clinical Pharmacology.2022; 78(5): 733. CrossRef

Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis

Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Kang Zuo, Elizabeth Lapshina, Madeline Mellett

Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis

Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review

Betsy Ann Joseph, Mahmoud Dibas, Kirk W. Evanson, Geeta Paranjape, Charan Thej Reddy Vegivinti, Pragadeesh Thamarai Selvan, Kavitha Saravu, Nitin Gupta, Yashwitha Sai Pulakurthi, Praneeth Reddy Keesari, Sriram Varsha, Spandana Chittajallu, Adam A. Dmytriw

Expert Review of Anti-infective Therapy.2021; 19(6): 679. CrossRef

Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective

Kavita Manchanda, Jasbir Singh, Ranjeev Bhagat, Ilmjot Kaur Tiwana, Harmanjit Singh

International Journal of Risk & Safety in Medicine.2021; 32(1): 3. CrossRef

A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Mo

Purwati, Budiono, Brian Eka Rachman, Yulistiani, Andang Miatmoko, Nasronudin, Soroy Lardo, Yongki Iswandi Purnama, Mafidhatul Laely, Ike Rochmad, Taufik Ismail, Sri Wulandari, Dwi Setyawan, Alfian Nur Rosyid, Herley Windo Setiawan, Prastuti Asta Wulan

Biochemistry Research International.2021; 2021: 1. CrossRef

Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study

Eun-Jeong Joo, Jae-Hoon Ko, Seong Eun Kim, Seung-Ji Kang, Ji Hyeon Baek, Eun Young Heo, Hye Jin Shi, Joong Sik Eom, Pyoeng Gyun Choe, Seongman Bae, Sang Hyun Ra, Da Young Kim, Baek-Nam Kim, Yu Min Kang, Ji Yeon Kim, Jin-Won Chung, Hyun-Ha Chang, Sohyun Ba

Journal of Korean Medical Science.2021;[Epub] CrossRef

Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19

Sun Bean Kim, Seungeun Ryoo, Kyungmin Huh, Eun-Jeong Joo, Youn Jeong Kim, Won Suk Choi, Yae-Jean Kim, Young Kyung Yoon, Jung Yeon Heo, Yu Bin Seo, Su Jin Jeong, Dong-ah Park, Su-Yeon Yu, Hyeon-Jeong Lee, Jimin Kim, Yan Jin, Jungeun Park, Kyong Ran Peck, M

Infection & Chemotherapy.2021; 53(1): 166. CrossRef

Repeat testing for SARS‐CoV‐2: persistence of viral RNA is common, and clearance is slower in older people

Paulina Stehlik, Kylie Alcorn, Anna Jones, Sanmarie Schlebusch, Andre Wattiaux, David A Henry

Medical Journal of Australia.2021; 214(10): 468. CrossRef

Justyna Olszewska-Parasiewicz, Łukasz Szarpak, Sylwester Rogula, Aleksandra Gąsecka, Urszula Szymańska, Maria Kwiatkowska, Milosz J. Jaguszewski, Radosław Sierpiński, Artur Zaczyński, Waldemar Wierzba, Dariusz A. Kosior

Mécanismes possiblement impliqués dans les effets antiviraux de la chloroquine et de l’hydroxychloroquine – Quelle réalité pour le traitement de la COVID-19 ?

Nessaibia Issam, Tichati Lazhari, Bouarroudj Tayeb, Siciliano Dafne, Bouslama Zihad, Merad Tarek, Tahraoui Abdelkrim

Toxicologie Analytique et Clinique.2021; 33(4): 237. CrossRef

Determination of Ligand Binding Modes in Hydrated Viral Ion Channels to Foster Drug Design and Repositioning

Balázs Zoltán Zsidó, Rita Börzsei, Viktor Szél, Csaba Hetényi

Journal of Chemical Information and Modeling.2021; 61(8): 4011. CrossRef

Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far

Md. Hossain, Tabassum Jannat, Shejuti Brishty, Urmi Roy, Saikat Mitra, Md. Rafi, Md. Islam, Mst. Nesa, Md. Islam, Talha Emran

Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip

Han Na Lee, Yoon Young Choi, Jin Won Kim, Young Seo Lee, Ji Wook Choi, Taewook Kang, Yong Kyun Kim, Bong Guen Chung

Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1

Olga Tarasova, Sergey Ivanov, Dmitry A. Filimonov, Vladimir Poroikov

Directly Acting Antivirals for COVID-19: Where Do We Stand?

Siew L. Teoh, Yi H. Lim, Nai M. Lai, Shaun W. H. Lee

Is there any potential management against COVID-19? A systematic review and meta-analysis

Haleh Talaie, Sayed Masoud Hosseini, Maryam Nazari, Yadollah Fakhri, Atieh Mousavizadeh, Hossein Vatanpour, Ali Firoozfar

DARU Journal of Pharmaceutical Sciences.2020; 28(2): 765. CrossRef

Yeungnam University Journal of Medicine.2020; 37(4): 286. CrossRef

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety

Saudi Pharmaceutical Journal.2020; 28(12): 1760. CrossRef

The Protease Inhibitor Lopinavir, Boosted with Ritonavir, as Treatment for COVID-19: A Rapid Review

Jienchi Dorward, Oghenekome Gbinigie, Ting Cai, Nia W Roberts, Nigel Garrett, Gail Hayward, Christopher C Butler